(Q38347370)

2 September 2017

1 reference

title

Who needs steroid receptor assays? (English)

1 reference

2 September 2017

D M Barnes

1

1 reference

2 September 2017

I S Fentiman

series ordinal

2

1 reference

2 September 2017

R R Millis

series ordinal

3

1 reference

2 September 2017

R D Rubens

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 May 1989

1 reference

2 September 2017

1 reference

2 September 2017

1

1 reference

2 September 2017

1126-1127

1 reference

2 September 2017

8647

1 reference

Hormone dependency of breast cancer

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Oestrogen receptors and prognosis in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Estrogen receptor level and other factors in early recurrence of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Estrogen receptor: A prognostic factor in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Influence and significance of certain prognostic factors on survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Steroid-hormone receptors and survival after first relapse in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Confirmation of a prognostic index in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Tamoxifen as initial sole treatment of localised breast cancer in elderly women: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Comparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Adjuvant endocrine therapy, cytotoxic chemotherapy, and immunotherapy in stage-II breast cancer: Five-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992395-7

7 January 2021

10.1016/S0140-6736(89)92395-7

Identifiers

DOI

1 reference

2 September 2017

1 reference